Company / EPS (Diluted)
Sabra Health Care REIT EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.06
FY2025
5-year range
-$0.52 / $0.67
FY2021-FY2025
Trend
+117.6%
vs FY2024
Sector context
#100 of 136
Real Estate
What the data says
At $0.06, Sabra Health Care REIT's eps (diluted) ranks #100 of 136 in the Real Estate sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-0.52 in FY2023 to $1.51 in FY2020.
Based on SEC 10-K filings.
0.06 in FY2025 with a 5-year CAGR of -47.5%.
Improved from $-0.52 to $0.06 over the past 2 years.
Real Estate sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -55.3%
- 5-Year CAGR
- -47.5%
- 10-Year CAGR
- -
Sector benchmark
#100 of 136 in Real EstateTop 74% of 136This company $0.06 Sector average $1.14
▼
-94.7% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 117.6% year-over-year.
- Ranks #100 out of 136 companies in the Real Estate sector.
- Peak eps (diluted) was recorded in FY2020.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | +117.6% |
| FY2024 | -$0.34 | +34.6% |
| FY2023 | -$0.52 | -177.6% |
| FY2022 | $0.67 | +81.1% |
| FY2021 | $0.37 | -75.5% |
| FY2020 | $1.51 | +7.9% |
| FY2019 | $1.40 | +52.2% |
| FY2018 | $0.92 | -17.1% |
| FY2017 | $1.11 | +42.3% |
| FY2016 | $0.78 | +14.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026